For more than a century, MSD (Merck Sharp & Dohme) has been a global healthcare leader for 125 years. MSD is a trade name of Merck & Co., Inc. with headquarters in Kenilworth, New Jersey, USA.
We discover, develop, manufacture and deliver innovative prescription medicines including biologic therapies and vaccines that help save and improve people’s lives. MSD portfolio include medicines for treatment and prevention of cancer, diabetes, hepatitis C, HIV and other infectious diseases, autoimmune inflammatory diseases, respiratory and cardiovascular diseases, etc.
We also execute and support partnership programs which contribute to improvement of access to health care.
MSD has been operating in Russia since 1991 with a focus on providing access to innovative medicines and vaccines, cooperation with local manufacturers and leading medical institutions as well as medical education support. We use our global expertize to contribute to the development of healthcare and pharmaceutical industry in Russia.